30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Oruka Therapeutics Inc (ORKA)

Track

Over the last 90 days, Oruka Therapeutics Inc. has seen significant insider selling, with a net value of -$306,914.76. Executives were net sellers, contributing to a negative net insider count. The majority of recent transactions were sales, including planned sales by senior executives like the Senior Vice President of Finance and the Chief Medical Officer.
Stock chart
Ticker: ORKA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Agarwal Arjun
Senior Vice President, Finance
4 sales — total 400,000 USD
Planned sale 22 Jun 2026
Value US$3,422,049.25 | Price 13.64 | Shares 88,822
Planned sale 22 Jun 2026
Value US$3,356,081.29 | Price 389.61 | Shares 33,213
Planned sale 22 Jun 2026
Value US$100,000.00 | Price 80.01 | Shares 1,000
Planned sale 22 Jun 2026
Value US$100,000.00 | Price 80.01 | Shares 1,000
Sale 15 Jun 2026
Value US$4,964,619.62 | Price 71.56 | Shares 72,070
Sale 15 Jun 2026
Value US$100,000.00 | Price 69.69 | Shares 1,000
Planned sale 15 Jun 2026
Value US$100,000.00 | Price 70.62 | Shares 1,000
Planned sale 15 Jun 2026
Value US$100,000.00 | Price 69.42 | Shares 1,000
Planned sale 15 Jun 2026
Value US$100,000.00 | Price 68.38 | Shares 1,000
Sale 15 Jun 2026
Value US$100,000.00 | Price 69.69 | Shares 1,000
Sale 15 Jun 2026
Value US$100,000.00 | Price 69.69 | Shares 1,000
Sale 15 Jun 2026
Value US$100,000.00 | Price 69.69 | Shares 1,000
Planned sale 12 Jun 2026
Value US$100,000.00 | Price 70.34 | Shares 1,000
Planned sale 12 Jun 2026
Value US$100,000.00 | Price 69.85 | Shares 1,000
Planned sale 12 Jun 2026
Value US$100,000.00 | Price 68.34 | Shares 1,000
Planned sale 12 Jun 2026
Value US$100,000.00 | Price 70.11 | Shares 1,000
Planned sale 12 Jun 2026
Value US$100,000.00 | Price 70.11 | Shares 1,000
Planned sale 11 Jun 2026
Value US$100,000.00 | Price 70.13 | Shares 1,000
Proposed sale 11 Jun 2026
Value US$100,000.00 | Price 64.03 | Shares 1,000
Proposed sale 11 Jun 2026
Value US$100,000.00 | Price 64.03 | Shares 1,000
Planned sale 21 May 2026
Value US$793,661.92 | Price 59.97 | Shares 13,235
Planned sale 21 May 2026
Value US$3,158,910.11 | Price 59.10 | Shares 53,447
Planned sale 21 May 2026
Value US$2,238,794.29 | Price 58.43 | Shares 38,318
Proposed sale 21 May 2026
Value US$6,370,350.00 | Price 60.67 | Shares 105,000
Proposed sale 21 May 2026
Value US$6,370,350.00 | Price 60.67 | Shares 105,000
Planned sale 18 May 2026
Value US$42,812.42 | Price 61.16 | Shares 700
Planned sale 18 May 2026
Value US$48,269.12 | Price 60.34 | Shares 800
Planned sale 18 May 2026
Value US$272,259.74 | Price 59.19 | Shares 4,600
Planned sale 18 May 2026
Value US$244,465.13 | Price 58.34 | Shares 4,190
Proposed sale 18 May 2026
Value US$1,375,217.58 | Price 61.93 | Shares 22,206
Planned sale 15 May 2026
Value US$6,352.00 | Price 63.52 | Shares 100
Planned sale 15 May 2026
Value US$131,088.30 | Price 62.42 | Shares 2,100
Planned sale 15 May 2026
Value US$295,494.72 | Price 61.56 | Shares 4,800
Planned sale 1 May 2026
Value US$6,848.00 | Price 68.48 | Shares 100
Planned sale 1 May 2026
Value US$13,431.00 | Price 67.16 | Shares 200
Planned sale 1 May 2026
Value US$26,422.00 | Price 66.06 | Shares 400
Planned sale 1 May 2026
Value US$19,530.00 | Price 65.10 | Shares 300
Planned sale 1 May 2026
Value US$115,467.84 | Price 64.15 | Shares 1,800
Planned sale 1 May 2026
Value US$137,685.46 | Price 62.58 | Shares 2,200
Proposed sale 1 May 2026
Value US$684,100.00 | Price 68.41 | Shares 10,000
Planned sale 15 Apr 2026
Value US$33,692.00 | Price 67.38 | Shares 500
Planned sale 15 Apr 2026
Value US$151,300.65 | Price 66.56 | Shares 2,273
Planned sale 15 Apr 2026
Value US$277,836.91 | Price 65.73 | Shares 4,227
Proposed sale 15 Apr 2026
Value US$1,408,260.00 | Price 67.06 | Shares 21,000
Sale 16 Mar 2026
Value US$71,407.70 | Price 41.30 | Shares 1,729
Sale 16 Mar 2026
Value US$16,313.50 | Price 41.30 | Shares 395
Sale 16 Mar 2026
Value US$24,780.00 | Price 41.30 | Shares 600
Sale 16 Mar 2026
Value US$26,473.30 | Price 41.30 | Shares 641
Planned sale 16 Mar 2026
Value US$49,358.79 | Price 41.94 | Shares 1,177
Planned sale 16 Mar 2026
Value US$119,568.78 | Price 41.20 | Shares 2,902
Planned sale 16 Mar 2026
Value US$117,158.68 | Price 40.11 | Shares 2,921
Sale 16 Mar 2026
Value US$30,272.90 | Price 41.30 | Shares 733
Planned sale 2 Mar 2026
Value US$90,435.60 | Price 33.81 | Shares 2,675
Planned sale 2 Mar 2026
Value US$77,386.00 | Price 33.28 | Shares 2,325
Planned sale 17 Feb 2026
Value US$30,686.01 | Price 32.78 | Shares 936
Planned sale 17 Feb 2026
Value US$195,872.66 | Price 32.30 | Shares 6,064
Planned sale 15 Jan 2026
Value US$84,428.70 | Price 32.24 | Shares 2,619
Planned sale 15 Jan 2026
Value US$138,275.75 | Price 31.56 | Shares 4,381
Proposed sale 2 Jan 2026
Value US$545,580.00 | Price 30.31 | Shares 18,000
Planned sale 2 Jan 2026
Value US$32,966.99 | Price 29.75 | Shares 1,108
Planned sale 2 Jan 2026
Value US$91,431.92 | Price 29.08 | Shares 3,144
Planned sale 2 Jan 2026
Value US$246,396.17 | Price 28.17 | Shares 8,748
Proposed sale 19 Dec 2025
Value US$788,200.00 | Price 28.15 | Shares 28,000
Planned sale 19 Dec 2025
Value US$97,263.32 | Price 31.58 | Shares 3,080
Planned sale 19 Dec 2025
Value US$45,806.04 | Price 30.70 | Shares 1,492
Planned sale 19 Dec 2025
Value US$52,934.51 | Price 29.62 | Shares 1,787
Planned sale 19 Dec 2025
Value US$18,289.14 | Price 28.53 | Shares 641
Buy 14 Feb 2025
Value US$1,015,803.36 | Price 11.44 | Shares 88,794
Buy 13 Feb 2025
Value US$173,868.50 | Price 11.63 | Shares 14,950
Buy 12 Feb 2025
Value US$106,396.06 | Price 11.86 | Shares 8,971
Buy 11 Feb 2025
Value US$105,043.35 | Price 10.95 | Shares 9,593
Buy 10 Feb 2025
Value US$6,256.60 | Price 10.90 | Shares 574
Buy 16 Aug 2024
Value US$1,274.07 | Price 2.98 | Shares 428
Buy 16 Aug 2024
Value US$15,792.70 | Price 2.93 | Shares 5,390
Buy 25 Jul 2024
Value US$92,292.10 | Price 3.05 | Shares 30,227
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-22 PlS Planned sale
Agarwal Arjun

Senior Vice President, Finance

Officer
88,822 -0.0%
13.64
US$3,422,049 		88,822 -0.0% 13.64 US$3,422,049
2026-06-22 2026-06-22 PlS Planned sale
Agarwal Arjun

Senior Vice President, Finance

Officer
33,213 +36.0%
389.61
US$3,356,081 		33,213 +36.0% 389.61 US$3,356,081
2026-06-22 2026-06-22 PlS Planned sale
Agarwal Arjun

Senior Vice President, Finance

Officer
36,290 -39.3%
310.69
US$44,827 		36,290 -39.3% 310.69 US$44,827
2026-06-22 2026-06-22 PlS Planned sale
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -5.3%
80.01
US$100,000 		1,000 -5.3% 80.01 US$100,000
2026-06-15 2026-06-15 S Sale
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -2.3%
69.69
US$100,000 		1,000 -2.3% 69.69 US$100,000
2026-06-15 2026-06-15 S Sale
Goncalves Joana

Chief Medical Officer

Officer
1,000 -2.8%
69.69
US$100,000 		1,000 -2.8% 69.69 US$100,000
2026-06-15 2026-06-15 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
1,000 -0.9%
70.62
US$100,000 		1,000 -0.9% 70.62 US$100,000
2026-06-15 2026-06-15 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
1,000 -13.0%
69.42
US$100,000 		1,000 -13.0% 69.42 US$100,000
2026-06-15 2026-06-15 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
1,000 -4.0%
68.38
US$100,000 		1,000 -4.0% 68.38 US$100,000
2026-06-15 2026-06-15 S Sale
Klein Lawrence Otto

Chief Executive Officer

Executive Director
1,000 -0.2%
69.69
US$100,000 		1,000 -0.2% 69.69 US$100,000
2026-06-15 2026-06-15 S Sale
Sandler Laura Lee

Chief Operating Officer

Officer
1,000 -0.3%
69.69
US$100,000 		1,000 -0.3% 69.69 US$100,000
2026-06-15 2026-06-15 S Sale
Quinlan Paul T

General Counsel

Officer
1,000 -2.3%
69.69
US$100,000 		1,000 -2.3% 69.69 US$100,000
2026-06-15 2026-06-12 PlS Planned sale
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -15.9%
70.34
US$100,000 		1,000 -15.9% 70.34 US$100,000
2026-06-15 2026-06-12 PlS Planned sale
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -17.4%
69.85
US$100,000 		1,000 -17.4% 69.85 US$100,000
2026-06-15 2026-06-12 PlS Planned sale
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -6.9%
68.34
US$100,000 		1,000 -6.9% 68.34 US$100,000
2026-06-12 2026-06-12 PlS Planned sale
Dambkowski Carl
Non-Executive Director
1,000 -24.5%
70.11
US$100,000 		1,000 -24.5% 70.11 US$100,000
2026-06-12 2026-06-12 PlS Planned sale
Dambkowski Carl
Non-Executive Director
1,000 -24.5%
70.11
US$100,000 		1,000 -24.5% 70.11 US$100,000
2026-06-12 2026-06-11 PlS Planned sale
Dambkowski Carl
Non-Executive Director
1,000 -30.4%
70.13
US$100,000 		1,000 -30.4% 70.13 US$100,000
2026-06-11 2026-06-11 PrS Proposed sale
CARL DAMBKOWSKI

Director

Non-Executive Director
1,000
64.03
US$100,000 		1,000 64.03 US$100,000
2026-06-11 2026-06-11 PrS Proposed sale
CARL DAMBKOWSKI

Director

Non-Executive Director
1,000
64.03
US$100,000 		1,000 64.03 US$100,000
2026-05-22 2026-05-21 PlS Planned sale
Dambkowski Carl
Non-Executive Director
13,235 -15.2%
59.97
US$793,662 		13,235 -15.2% 59.97 US$793,662
2026-05-22 2026-05-21 PlS Planned sale
Dambkowski Carl
Non-Executive Director
53,447 -38.1%
59.10
US$3,158,910 		53,447 -38.1% 59.10 US$3,158,910
2026-05-22 2026-05-21 PlS Planned sale
Dambkowski Carl
Non-Executive Director
38,318 -21.4%
58.43
US$2,238,794 		38,318 -21.4% 58.43 US$2,238,794
2026-05-21 2026-05-21 PrS Proposed sale
CARL DAMBKOWSKI

Director

Non-Executive Director
105,000
60.67
US$6,370,350 		105,000 60.67 US$6,370,350
2026-05-21 2026-05-21 PrS Proposed sale
CARL DAMBKOWSKI

Director

Non-Executive Director
105,000
60.67
US$6,370,350 		105,000 60.67 US$6,370,350
2026-05-18 2026-05-18 PlS Planned sale
Agarwal Arjun

Senior Vice President, Finance

Officer
700 -4.1%
61.16
US$42,812 		700 -4.1% 61.16 US$42,812
2026-05-18 2026-05-18 PlS Planned sale
Agarwal Arjun

Senior Vice President, Finance

Officer
800 -4.5%
60.34
US$48,269 		800 -4.5% 60.34 US$48,269
2026-05-18 2026-05-18 PlS Planned sale
Agarwal Arjun

Senior Vice President, Finance

Officer
4,600 -20.4%
59.19
US$272,260 		4,600 -20.4% 59.19 US$272,260
2026-05-18 2026-05-18 PlS Planned sale
Agarwal Arjun

Senior Vice President, Finance

Officer
4,190 -15.7%
58.34
US$244,465 		4,190 -15.7% 58.34 US$244,465
2026-05-18 2026-05-18 PrS Proposed sale
ARJUN AGARWAL

Officer

Officer
22,206
61.93
US$1,375,218 		22,206 61.93 US$1,375,218
2026-05-15 2026-05-15 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
100 -0.3%
63.52
US$6,352 		100 -0.3% 63.52 US$6,352
2026-05-15 2026-05-15 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,100 -5.9%
62.42
US$131,088 		2,100 -5.9% 62.42 US$131,088
2026-05-15 2026-05-15 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
4,800 -11.9%
61.56
US$295,495 		4,800 -11.9% 61.56 US$295,495
2026-05-01 2026-05-01 PlS Planned sale
Sandler Laura Lee

Chief Operating Officer

Officer
100 -0.0%
68.48
US$6,848 		100 -0.0% 68.48 US$6,848
2026-05-01 2026-05-01 PlS Planned sale
Sandler Laura Lee

Chief Operating Officer

Officer
200 -0.1%
67.16
US$13,431 		200 -0.1% 67.16 US$13,431
2026-05-01 2026-05-01 PlS Planned sale
Sandler Laura Lee

Chief Operating Officer

Officer
400 -0.2%
66.06
US$26,422 		400 -0.2% 66.06 US$26,422
2026-05-01 2026-05-01 PlS Planned sale
Sandler Laura Lee

Chief Operating Officer

Officer
300 -0.1%
65.10
US$19,530 		300 -0.1% 65.10 US$19,530
2026-05-01 2026-05-01 PlS Planned sale
Sandler Laura Lee

Chief Operating Officer

Officer
1,800 -0.8%
64.15
US$115,468 		1,800 -0.8% 64.15 US$115,468
2026-05-01 2026-05-01 PlS Planned sale
Sandler Laura Lee

Chief Operating Officer

Officer
2,200 -0.9%
62.58
US$137,685 		2,200 -0.9% 62.58 US$137,685
2026-05-01 2026-05-01 PrS Proposed sale
LAURA SANDLER

Officer

Officer
10,000
68.41
US$684,100 		10,000 68.41 US$684,100
2026-04-15 2026-04-15 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
500 -1.5%
67.38
US$33,692 		500 -1.5% 67.38 US$33,692
2026-04-15 2026-04-15 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,273 -6.3%
66.56
US$151,301 		2,273 -6.3% 66.56 US$151,301
2026-04-15 2026-04-15 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
4,227 -10.5%
65.73
US$277,837 		4,227 -10.5% 65.73 US$277,837
2026-04-15 2026-04-15 PrS Proposed sale
JOANA GONCALVES

Officer

Officer
21,000
67.06
US$1,408,260 		21,000 67.06 US$1,408,260
2026-03-17 2026-03-16 S Sale
Klein Lawrence Otto

Chief Executive Officer

Executive Director
1,729 -0.2%
41.30
US$71,408 		1,729 -0.2% 41.30 US$71,408
2026-03-17 2026-03-16 S Sale
Agarwal Arjun

Senior Vice President, Finance

Officer
395 -2.1%
41.30
US$16,313 		395 -2.1% 41.30 US$16,313
2026-03-17 2026-03-16 S Sale
Sandler Laura Lee

Chief Operating Officer

Officer
600 -0.3%
41.30
US$24,780 		600 -0.3% 41.30 US$24,780
2026-03-17 2026-03-16 S Sale
Goncalves Joana

Chief Medical Officer

Officer
641 -1.9%
41.30
US$26,473 		641 -1.9% 41.30 US$26,473
2026-03-17 2026-03-16 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
1,177 -3.3%
41.94
US$49,359 		1,177 -3.3% 41.94 US$49,359
2026-03-17 2026-03-16 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,902 -7.6%
41.20
US$119,569 		2,902 -7.6% 41.20 US$119,569
2026-03-17 2026-03-16 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,921 -7.1%
40.11
US$117,159 		2,921 -7.1% 40.11 US$117,159
2026-03-17 2026-03-16 S Sale
Quinlan Paul T

General Counsel

Officer
733 -2.3%
41.30
US$30,273 		733 -2.3% 41.30 US$30,273
2026-03-02 2026-03-02 PlS Planned sale
Sandler Laura Lee

Chief Operating Officer

Officer
2,675 -1.1%
33.81
US$90,436 		2,675 -1.1% 33.81 US$90,436
2026-03-02 2026-03-02 PlS Planned sale
Sandler Laura Lee

Chief Operating Officer

Officer
2,325 -1.0%
33.28
US$77,386 		2,325 -1.0% 33.28 US$77,386
2026-02-17 2026-02-17 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
936 -2.7%
32.78
US$30,686 		936 -2.7% 32.78 US$30,686
2026-02-17 2026-02-17 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
6,064 -14.8%
32.30
US$195,873 		6,064 -14.8% 32.30 US$195,873
2026-01-16 2026-01-15 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,619 -63.3%
32.24
US$84,429 		2,619 -63.3% 32.24 US$84,429
2026-01-16 2026-01-15 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
4,381 -51.4%
31.56
US$138,276 		4,381 -51.4% 31.56 US$138,276
2026-01-02 2026-01-02 PrS Proposed sale
LAURA SANDLER

Officer

Officer
18,000
30.31
US$545,580 		18,000 30.31 US$545,580
2026-01-02 2026-01-02 PlS Planned sale
Sandler Laura Lee

Chief Operating Officer

Officer
1,108 -0.5%
29.75
US$32,967 		1,108 -0.5% 29.75 US$32,967
2026-01-02 2026-01-02 PlS Planned sale
Sandler Laura Lee

Chief Operating Officer

Officer
3,144 -1.5%
29.08
US$91,432 		3,144 -1.5% 29.08 US$91,432
2026-01-02 2026-01-02 PlS Planned sale
Sandler Laura Lee

Chief Operating Officer

Officer
8,748 -4.0%
28.17
US$246,396 		8,748 -4.0% 28.17 US$246,396
2025-12-19 2025-12-19 PrS Proposed sale
JOANA GONCALVES

Officer

Officer
28,000
28.15
US$788,200 		28,000 28.15 US$788,200
2025-12-19 2025-12-19 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
3,080 -67.0%
31.58
US$97,263 		3,080 -67.0% 31.58 US$97,263
2025-12-19 2025-12-19 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
1,492 -24.5%
30.70
US$45,806 		1,492 -24.5% 30.70 US$45,806
2025-12-19 2025-12-19 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
1,787 -22.7%
29.62
US$52,935 		1,787 -22.7% 29.62 US$52,935
2025-12-19 2025-12-19 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
641 -7.5%
28.53
US$18,289 		641 -7.5% 28.53 US$18,289
2025-02-27 2025-02-14 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
88,794 +2.2%
11.44
US$1,015,803 		88,794 +2.2% 11.44 US$1,015,803
2025-02-27 2025-02-13 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
14,950 +0.4%
11.63
US$173,868 		14,950 +0.4% 11.63 US$173,868
2025-02-27 2025-02-12 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
8,971 +0.2%
11.86
US$106,396 		8,971 +0.2% 11.86 US$106,396
2025-02-27 2025-02-11 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
9,593 +0.2%
10.95
US$105,043 		9,593 +0.2% 10.95 US$105,043
2025-02-27 2025-02-10 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
574 +0.0%
10.90
US$6,257 		574 +0.0% 10.90 US$6,257
2024-08-20 2024-08-16 B Purchase
3.1
JANUS HENDERSON GROUP PLC
Large shareholder
428 +0.0%
2.98
US$1,274 		428 +0.0% 2.98 US$1,274
2024-08-20 2024-08-16 B Purchase
3.1
JANUS HENDERSON GROUP PLC
Large shareholder
5,390 +0.3%
2.93
US$15,793 		5,390 +0.3% 2.93 US$15,793
2024-07-26 2024-07-25 B Purchase
3.1
JANUS HENDERSON GROUP PLC
Large shareholder
30,227 +1.5%
3.05
US$92,292 		30,227 +1.5% 3.05 US$92,292
Explore more

More insider trading research around Oruka Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America